2017 American Transplant Congress

Saturday, April 29, 2017

5:30pm-7:30pm

Identification of Kidney Transplant Patients at Risk for Skin Cancer by Differentially Methylated Regions in T Cells.

F. Peters,¹ A. Peeters,¹ P. Mandaviya,² J. van de Wetering,¹ M. Betjes,¹ C. Baan,¹ K. Boer.¹

Poster Session A: Diagnostics/Biomarkers Session I  •  Hall D1

5:30pm-7:30pm

Identification of NKG2D as Senescence Marker in Zero-Hour Kidney Biopsies Is Indicative for Clinical Outcome.

T. Resch,¹ J. Günther,¹ H. Hackl,² A. Sattler,³ S. Ebner,¹ P. Ritschl,³ M. Biebl,³ R. Öllinger,³ S. Schneeberger,¹ G. Brandacher,⁴ H. Schwelberger,¹ B. Zelger,⁵ D. Stauch,³ A. Pascher,³ J. Pratschke,³ K. Kotsch.³

Poster Session A: Diagnostics/Biomarkers Session I  •  Hall D1

5:30pm-7:30pm

Identification of Novel Diagnostic Biomarkers in Liver Transplantation Tolerance.

G.-Q. Shen,¹ M. Morita,¹ C. Miller,¹ K. Hashimoto,¹ L. Lu,¹ S. Qian,¹ J. Fung.²

Poster Session A: Diagnostics/Biomarkers Session I  •  Hall D1

5:30pm-7:30pm

IdeS, an IgG Endopeptidase, Effectively Cleaves Anti-CMV IgG, Resulting in Inhibition of Antibody (Ab)-Mediated NK Cell Activation in Kidney Transplant Patients (KTX Pts).

B.-H. Shin,¹ S. Ge,¹ M. Chu,¹ J. Choi,¹ L. Winstedt,² C. Kjellman,² S. Louie,¹ A. Vo,¹ A. Peng,¹ S. Jordan,¹ M. Toyoda.¹

Poster Session A: Antibody Mediated Rejection in Kidney Transplant Recipients I  •  Hall D1

5:30pm-7:30pm

IgG Antibody Subclasses in Potential Renal Transplant Recipients with DSA, AHG-CDC CxM Negative and FxM Positive or Negative with Their Potential Donors.

A. Contreras, A. Casillas, L. Llorente, G. Lima, A. Arvizu, A. De Santiago, M. Vilatoba, J. Alberu, J. Arreola-Guerra.

Poster Session A: Living Donor Kidney Transplant I  •  Hall D1

5:30pm-7:30pm

Immediate vs Delayed Initiation of CMV Prophylaxis…Safe and Cost Beneficial?

L. Cotiguala, A. Carlson, C. Truax, B. Sirandas, I. Hall, L. Smith.

Poster Session A: Viral Conundrums  •  Hall D1

5:30pm-7:30pm

Immunosuppressive Ability of NFkB Inhibitor: Withaferin A.

M. Kanak,¹ Y. Shindo,¹ M. Levy,^1,2 B. Naziruddin.³

Poster Session A: Immunosuppression  •  Hall D1

5:30pm-7:30pm

Immunosuppressive Regimen Modification Approaches in BK Nephropathy – A Comparative Study.

H. Ahmed, A. Roche-Recinos, C. Drachenberg, R. Ugarte, N. Costa, M. Mavanur, B. Thomas, A. Haririan.

Poster Session A: Kidney: Polyoma  •  Hall D1

5:30pm-7:30pm

Immunosuppressive Treatment Alters Gut Microbiota and Modified Gut Microbiota Affects Immune Status.

Z. Zhang, Y. Xu, Q. Zhang, X. Hu.

Poster Session A: Immunosuppression  •  Hall D1

5:30pm-7:30pm

Impact of a Novel Prehabilitation Program in Kidney Transplant Candidates.

M. McAdams DeMarco, H. Ying, A. Nastasi, D. Segev.

Poster Session A: Deceased Donor Issues I: Allocation, KDPI and Recipient Selection  •  Hall D1